Callaghan R Garland

Maternally transferred monoclonal antibodies protect neonatal mice from herpes simplex virus-induced mortality and morbidity

S. Davis, A. Balazs, M. Ackerman, 2022, bioRxiv.

Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity

S. Davis, A. Balazs, M. Ackerman, 2022, The Journal of experimental medicine.

Antibody effector functions are required for broad and potent protection of neonates from herpes simplex virus infection

Matthew D. Slein, Iara M. Backes, Callaghan R Garland, 2023, bioRxiv.

Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D

Matthew D. Slein, Iara M. Backes, Callaghan R Garland, 2024, Cell reports. Medicine.